Abiopharma

🔍 Kini Vikram (Executive)

Company: Ingersoll Rand Inc. (IR)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Acquired 898 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 103,485.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 390 shares of Common Stock at $79.33 per share (Direct)
  Date: 2026-08-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 103,095.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 898 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,796.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: These restricted stock units vest in four equal annual installments beginning on August 20, 2025 and upon vesting, will each be settled by delivery of one share of common stock, an equivalent amount of cash, or a combination thereof.
• F2: Represents shares withheld to pay taxes applicable to vesting of restricted stock units.